エドとチャットする

その他

ポートフォリオ

ミッション

フォローする

EN

戻る



healthcare: pharmaニュース

あなたのために市場経済テクノロジーとAI 暗号資産エネルギー医療香港および中国ファイナンス

製薬

バイオテクノロジー

保健サービス

医療機器

Replimune's TUDRIQEV wins FDA approval with 24.2% response rate

Replimune's TUDRIQEV wins FDA approval with 24.2% response rate

Aug 14 2026, 12:34

Capricor shares double as FDA agrees to review Duchenne drug data

Capricor shares double as FDA agrees to review Duchenne drug data

Aug 14 2026, 11:06

EMA validates Pfizer-Valneva Lyme vaccine as efficacy tops 70%

EMA validates Pfizer-Valneva Lyme vaccine as efficacy tops 70%

Aug 14 2026, 05:30

China pharma sector surges 30% as institutions pile into innovative drugs

China pharma sector surges 30% as institutions pile into innovative drugs

Aug 14 2026, 00:17

FDA approves BMS's ZENBEXUS, first CELMoD, doubling MRD-negative CR to 41%

FDA approves BMS's ZENBEXUS, first CELMoD, doubling MRD-negative CR to 41%

Aug 13 2026, 21:31

Appeals court revives $6.7 billion Bristol Myers Celgene lawsuit

Appeals court revives $6.7 billion Bristol Myers Celgene lawsuit

Aug 13 2026, 17:10

MapLight Therapeutics raises $150 million to fund CNS drug trials

MapLight Therapeutics raises $150 million to fund CNS drug trials

Aug 13 2026, 13:36

OS Therapies secures FDA statistical meeting on 2.5-year survival data

OS Therapies secures FDA statistical meeting on 2.5-year survival data

Aug 13 2026, 13:05

Rigel launches VEPPANU, first FDA-approved PROTAC, at $29,400 monthly

Rigel launches VEPPANU, first FDA-approved PROTAC, at $29,400 monthly

Aug 13 2026, 12:38

Novo CEO sees obesity market beyond winner-take-all as 100 million untreated

Novo CEO sees obesity market beyond winner-take-all as 100 million untreated

Aug 13 2026, 10:40

Definium's DT120 meets Phase 3 GAD endpoint with 5.4-point HAM-A gain

Definium's DT120 meets Phase 3 GAD endpoint with 5.4-point HAM-A gain

Aug 13 2026, 10:36

Novo CEO defends Lilly suit as Wegovy pill tops 5 million

Novo CEO defends Lilly suit as Wegovy pill tops 5 million

Aug 13 2026, 00:37

Akeso wins third NMPA approval as ivonescimab cuts death risk 34%

Akeso wins third NMPA approval as ivonescimab cuts death risk 34%

Aug 12 2026, 15:44

Belite Bio wins FDA priority review for tinlarebant, PDUFA Feb 2027

Belite Bio wins FDA priority review for tinlarebant, PDUFA Feb 2027

Aug 12 2026, 14:05

Lilly sues six companies over black-market retatrutide sales

Lilly sues six companies over black-market retatrutide sales

Aug 12 2026, 10:05

BridgeBio beats Q2 revenue as Attruby sales surge 211% to $222.4M

BridgeBio beats Q2 revenue as Attruby sales surge 211% to $222.4M

Aug 11 2026, 18:08

United Laboratories wins FDA nod for obesity drug UBT48128

United Laboratories wins FDA nod for obesity drug UBT48128

Aug 11 2026, 15:11

CSPC Pharma monkeypox vaccine wins FDA nod as shares slip 0.7%

CSPC Pharma monkeypox vaccine wins FDA nod as shares slip 0.7%

Aug 10 2026, 15:18

Novo Nordisk taps AWS for AI drug push, 25,000 staff onboard

Novo Nordisk taps AWS for AI drug push, 25,000 staff onboard

Aug 10 2026, 13:12

Regeneron faces $11 billion wipeout lawsuit after melanoma trial fails

Regeneron faces $11 billion wipeout lawsuit after melanoma trial fails

Aug 10 2026, 12:37

特徴

株式・暗号通貨用AIコピローター

資金調達トラッカー

暗号通貨比較

ホームページ

Markets

News

AI & Technology

利用規約プライバシーポリシーサイトマップ

© 2026 Edgen によって提供